HIV virus decrease in semen and rectum in patients HIV+ men, who starts treatment with dolutegravir plus lamivudine compared to Bictegravir/FTC/TAF

Registry ID

EUCTR2019-004109-28

Source registry

EUCTR

Status

Ongoing

Phase

PHASE4

Sponsor

Daniel Podzamczer Palter

Start date

2020-01-17

Last update

2026-08-16

Conditions

• HIV infection

Summary

To compare HIV-1 RNA decay kinetics in semen in ART-naïve HIV-1 infected male individuals treated with DTG/3TC dual therapy versus BIC/FTC/TAF.

Locations

• , , Spain

View on source registry